← Back to Search

Tympanostomy Tube System

Hummingbird Tympanostomy Tube System (H-TTS) for Ear Infection

N/A

Waitlist Available

Research Sponsored by Preceptis Medical, Inc.

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be younger than 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up intra-procedure

Awards & highlights

Study Summary

This trial is testing how safe and effective a new device is for placing ear tubes in children 2-21 years old.

Eligible Conditions

Ear Infection

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ follow-up between 3-10 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~follow-up between 3-10 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and follow-up between 3-10 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Percentage of Ears With Successful Delivery of the Tympanostomy Tube by the H-TTS

Percentage of Participants With Successful Completion of Procedure In-office

Rate of Ears Experiencing an Adverse Events From Enrollment to 3-10 Week Follow-up

Trial Design

1Treatment groups

Experimental Treatment

Group I: Hummingbird Tympanostomy Tube System (H-TTS)Experimental Treatment1 Intervention

The Hummingbird Tympanostomy Tube System (H-TTS) is a disposable surgical tool designed to deliver a tympanostomy tube ("ear tube") into the tympanic membrane of patients during a tympanostomy tube placement procedure.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Hummingbird Tympanostomy Tube System (H-TTS)

2018

N/A

~260

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Preceptis Medical, Inc.Lead Sponsor

2 Previous Clinical Trials

308 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

To what population is enrollment in this experiment open?

"Candidates between the ages of 2 and 21 who are suffering from otitis media can sign up for this study. Approximately 80 participants need to be enrolled in total."

Answered by AI

Is it feasible to join this trial at present?

"It appears that, according to clinicaltrials.gov, this research project is currently recruiting participants. The trial has been publicly available since July 24th 2018 and was last modified on April 20th 2022."

Answered by AI

To what capacity is this medical experiment accommodating participants?

"Affirmative. The data hosted on clinicaltrials.gov makes clear that this medical experiment, published on July 24th 2018, is presently enrolling volunteers. Approximately 80 individuals must be recruited from 5 different sites for the trial to proceed as planned."

Answered by AI

Are applicants younger than thirty being accepted into this research study?

"Eligible participants for this medical trial must be between 2 and 21 years of age."

Answered by AI

Are there any centers conducting this medical study within North America's borders?

"Presently, there are 5 clinical trial sites recruiting patients for this medical study. Locations include Rochester, Saint Cloud and Saint Louis Park alongside two other locales. If you plan to enroll in the trial, it is advisable to select a site close by which will minimize travel demands."

Answered by AI

Recent research and studies

Laryngoscope Investigative OtolaryngologyJournal

In‐office Insertion Tympanostomy Tubes in Children Using <scp>single‐pass</scp> Device

Truitt, Theodore O., James R. Kosko, Grace L. Nimmons, Jay Raisen, Sandra M. Skovlund, Frank Rimell, and Shelagh A. Cofer. 2021. “In‐office Insertion Tympanostomy Tubes in Children Using single‐pass Device”. Laryngoscope Investigative Otolaryngology. Wiley. doi:10.1002/lio2.533.

clinicaltrials.govStudy

In-Office Study of the Hummingbird® in Children 6 Months-21 Years Old

2018. "In-Office Study of the Hummingbird® in Children 6 Months-21 Years Old". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03544138.